Back
RosCan Gold Corp. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
29
RCGCF
RosCan Gold Corp.
Last Price:
$0.09
Seasonality Move:
-1.85%
Sell
34
MNPR
Monopar Therapeutics, Inc.
Last Price:
$64.98
Seasonality Move:
25.93%
Sell
29
RosCan Gold Corp. (RCGCF)
is a Sell
Is RosCan Gold Corp. a Buy, Sell or Hold?
-
The current RosCan Gold Corp. [RCGCF] share price is $0.09. The Score for RCGCF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
RCGCF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $67.70. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCGCF Stock Price Chart
What is RosCan Gold Corp.'s stock price today?
-
The RosCan Gold Corp. share price today is $0.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCGCF is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $67.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
RCGCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 49.27 | Sell |
| Chaikin Money Flow: | -104428 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.07 - 0.09) | Buy |
| Bollinger Bands (100): | (0.06 - 0.1) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.86 | Sell |
| Relative Strength Index (14 RSI): | 33.87 | Sell |
| Chaikin Money Flow: | -124010 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.34 - 86.38) | Sell |
| Bollinger Bands (100): | (44.81 - 88.99) | Buy |
RCGCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.09 | Sell |
| 20-day SMA: | 0.09 | Sell |
| 50-day SMA: | 0.08 | Buy |
| 200-day SMA: | 0.06 | Buy |
| 8-day EMA: | 0.02 | Buy |
| 20-day EMA: | 0.01 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.5 | Sell |
| 20-day SMA: | 80.22 | Sell |
| 50-day SMA: | 82.77 | Sell |
| 200-day SMA: | 51.96 | Buy |
| 8-day EMA: | 74.03 | Sell |
| 20-day EMA: | 77.79 | Sell |
| 50-day EMA: | 77.58 | Sell |
| 200-day EMA: | 56.47 | Buy |
RosCan Gold Corp. Earnings Growth & RCGCF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
RosCan Gold Corp. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||